Verano (OTCMKTS:VRNOF – Get Free Report) and Heart Tronics (OTCMKTS:HRTT – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, profitability, valuation, dividends and risk.
Insider and Institutional Ownership
9.0% of Verano shares are held by institutional investors. 9.1% of Verano shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Analyst Ratings
This is a breakdown of recent recommendations and price targets for Verano and Heart Tronics, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Verano | 1 | 0 | 0 | 1 | 2.50 |
| Heart Tronics | 0 | 0 | 0 | 0 | 0.00 |
Profitability
This table compares Verano and Heart Tronics’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Verano | -41.68% | -9.54% | -4.51% |
| Heart Tronics | N/A | N/A | N/A |
Valuation & Earnings
This table compares Verano and Heart Tronics”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Verano | $878.59 million | 0.52 | -$341.86 million | ($0.98) | -1.29 |
| Heart Tronics | N/A | N/A | N/A | N/A | N/A |
Heart Tronics has lower revenue, but higher earnings than Verano.
Summary
Verano beats Heart Tronics on 5 of the 9 factors compared between the two stocks.
About Verano
Verano Holdings Corp. operates as a vertically integrated multi-state cannabis operator in the United States. The company engages in the cultivation, processing, wholesale, and retail distribution of cannabis in Arizona, Arkansas, Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, Nevada, New Jersey, Ohio, Pennsylvania, and West Virginia. It offers cannabis products under the Encore, Avexia, MUV, Savvy, BITS, and Verano brands for medical and adult-use markets. The company is headquartered in Chicago, Illinois.
About Heart Tronics
Heart Tronics, Inc., a medical device company, engages in the research, development, and marketing of medical devices in the United States. Its medical devices are used to monitor and measure physiological signals in order to detect diseases that impact an individual's health. The company offers Fidelity 100 Monitor System, an integrated system in which its component Model 100 Patient Module collects, processes, and amplifies electrocardiogram (ECG) signals from that patient through a set of 10 electrodes that are wirelessly transmitted to the laptop computer. Its products in the development stage include Fidelity 350 Holter Monitor, an ambulatory Holter monitor that collects ECG data of arrhythmia and transient heart disease, while the patient carries out daily activities away from the physician's office or hospital. The company's products in the development stage also consist of Fidelity 200 Event Recording System/Heart Tempo Card, a non-prescription heart monitoring device, which is used as an early-detection device by patients who desire to monitor their condition. Its products also include Cardiac Vest, a lightweight, close-fitting vest or undergarment made of stretchable material in which the electrodes are stitched into the fabric; and Fidelity 400 Intracardiac Monitor that applies its proprietary physiological signal acquisition and amplification technology to read intracardiac signals procured from intracardiac catheter. The company was formerly known as Signalife, Inc. and changed its name to Heart Tronics, Inc. in November 2008. Heart Tronics, Inc. was incorporated in 1987 is headquartered in Studio City, California.
Receive News & Ratings for Verano Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verano and related companies with MarketBeat.com's FREE daily email newsletter.
